National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.
Saved in:
| Title: | National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations. |
|---|---|
| Authors: | Einstein DJ; Beth Israel Deaconess Medical Center, Boston, MA., Abel ML; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Aragon-Ching JB; Inova Schar Cancer Institute, Fairfax, VA., Arlen PM; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Autio KA; Memorial Sloan Kettering Cancer Center, New York, NY., Bilusic M; Division of Medical Oncology, University of Miami Miller School of Medicine, Miami, FL., Carducci MA; Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Choyke PL; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Citrin DE; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Figg WD; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Graff JN; Portland Veteran's Administration, Portland, OR., Gulley JL; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Halabi S; Division of Biostatistics, Duke University School of Medicine, Durham, NC., Karzai F; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Lindenberg L; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Markowski MC; Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Marshall CH; Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., McNeel DG; Department of Medicine, University of Wisconsin, Madison, WI., Mena E; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Moon H; Department of Research & Evaluation, Kaiser Permanente Riverside Medical Center, Riverside, CA., Pachynski RK; Division of Oncology, Washington University, St Louis, MO., Paller CJ; Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Patel KR; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Posadas EM; Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA., Pienta KJ; Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA., Sena LA; Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Walmsley CS; Beth Israel Deaconess Medical Center, Boston, MA., Wei XX; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Yu EY; Fred Hutchinson Cancer Center, Seattle, WA., Tran PT; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD., Madan RA; Center for Cancer Research, National Cancer Institute, Bethesda, MD. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Dec; Vol. 43 (34), pp. 3672-3683. Date of Electronic Publication: 2025 Oct 23. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
